THORLNC and breast cancer: Amongst the cell lines analyzed, the MCF-7 cell line was selected to evaluate the effect of targeted THOR demethylation in BC, since it has THOR hypermethylated (around 95%), does not harbor hTERT promoter mutations, and expresses hTERT (Additional file 3: Fig. S3 and Additional file 14: Table S2).